Lv2
125 积分 2024-09-04 加入
Prevalence and Risk Factors for AKI in Patients with Nephrotic Syndrome and Nephrotic-Range Proteinuria
1个月前
已关闭
Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides
2个月前
已完结
SAT0286 Paediatric Vasculitis Damage Index: A New Tool for Standardised Disease Assessment
2个月前
已完结
Modification and validation of the Birmingham Vasculitis Activity Score (version 3)
2个月前
已完结
Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS)
2个月前
已完结
Obinutuzumab in untreated primary membranous nephropathy: An observational case series
2个月前
已完结
Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)
2个月前
已完结
Proteinuria and hematuria after remission induction are associated with outcome in ANCA-associated vasculitis
2个月前
已完结
Rituximab Versus Cyclophosphamide for Central Nervous System Involvement of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Case Series
3个月前
已完结
Telitacicept for refractory IgA nephropathy: a case series
3个月前
已完结